Erenumab efficacy in highly resistant chronic migraine: a real-life study

Neurol Sci. 2020 Dec;41(Suppl 2):457-459. doi: 10.1007/s10072-020-04658-1.

Authors

Affiliations

¹ Department of Biomedical and NeuroMotor Sciences (DiBiNeM), Alma Mater Studiorum - University of Bologna Italy, Bologna, Italy.
² IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
³ IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy. s.cevoli@isnb.it.

PMID: 32852684
DOI: 10.1007/s10072-020-04658-1

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized* / therapeutic use
Calcitonin Gene-Related Peptide Receptor Antagonists
Humans
Migraine Disorders* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
Calcitonin Gene-Related Peptide Receptor Antagonists
erenumab